Okay, I reread your post and see that was about a last resort type of deal. Hopefully, the BOD reigns in his ego. A JV with a chunk of cash to keep Research and trials going with other diseases would be better for us in the long run, but a buyout at a high enough price would certainly go thru and benefit us short term. But, just once it would be nice to ride a 100+ bagger into the sunset. But, just as OCAT was stolen, this too shall be, imo.
T
News 
Market Data 
Discover 
